Tranxene Shortage Update: What Patients Need to Know in 2026

If you take Tranxene (clorazepate dipotassium) for anxiety, seizures, or alcohol withdrawal, you may have noticed that filling your prescription has gotten more complicated. Pharmacies are out of stock. Wholesalers can't deliver. And nobody seems to have a clear answer. Here's the most current picture of what's happening with Tranxene supply in 2026 — and what you can do about it.

Is Tranxene Officially in Shortage in 2026?

As of early 2026, clorazepate (Tranxene) is not formally listed on the FDA Drug Shortage Database. But that doesn't mean there's no problem. The FDA's shortage list only captures medications where manufacturers have notified the FDA of a shortage — many real-world availability issues never make that list. What patients are experiencing with clorazepate in 2026 is best described as a "soft shortage": the drug is manufactured and not discontinued, but limited manufacturer participation and low pharmacy stocking rates mean it's genuinely difficult to find at many locations.

What's Driving the Availability Problems?

Several factors combine to make clorazepate one of the harder benzodiazepines to fill in 2026:

Thin manufacturer base: Recordati Rare Diseases Inc. produces the brand-name Tranxene, and historically only a small number of companies have manufactured the generic. Any disruption — raw material issues, regulatory actions, or manufacturing problems — affects the entire supply.

Low prescribing volume: Clorazepate is prescribed far less often than alprazolam (Xanax), lorazepam (Ativan), or clonazepam (Klonopin). Lower demand means pharmacies are less motivated to carry it as a standard item.

DEA quota system: As a Schedule IV controlled substance, federal manufacturing quotas limit how much clorazepate can be produced annually. Wholesalers also face distributor limits on how much they can ship.

Ongoing supply chain pressures: Post-pandemic supply chain disruptions continue to affect raw material sourcing and API manufacturing for many medications, including less commonly used ones like clorazepate.

Good News: A New Generic Manufacturer Entered the Market in 2026

There's meaningful positive news for patients. In early 2026, ANI Pharmaceuticals received FDA approval for a new generic clorazepate dipotassium tablet. This is significant: adding another manufacturer to the market should increase total supply over time and may also put downward pressure on prices as competition increases. The US clorazepate market is approximately $25.8 million annually, which is enough to support multiple generic producers. As ANI's product rolls out to pharmacy wholesalers, availability should gradually improve.

What Does Tranxene Cost in 2026?

Without insurance, retail prices for a 30-day supply of generic clorazepate 7.5 mg tablets range from about $29 to $155 depending on the pharmacy. The average retail price is roughly $141 — but with a GoodRx or SingleCare coupon, you can often pay as low as $28-34. This wide spread means the pharmacy you choose can make a $100+ difference in your out-of-pocket cost.

With insurance, generic clorazepate is typically covered as a Tier 1 or Tier 2 drug on most formularies, with copays ranging from $0-30 per fill. However, your plan may impose quantity limits or require prior authorization for benzodiazepines — check with your insurer or pharmacist.

What to Do Right Now If You Can't Find Tranxene

Here are steps to take immediately if your pharmacy is out of stock:

Use medfinder: medfinder calls pharmacies near you to find which ones can fill your Tranxene prescription. Go to medfinder.com and enter your medication details and location.

Try independent pharmacies: Independent and regional pharmacies are more willing to special-order clorazepate and may have better access through different wholesalers.

Ask about special orders: Even chain pharmacies may be able to order clorazepate from their wholesaler within 1-2 business days — ask explicitly.

Contact your prescriber: Keep your doctor informed. If you're consistently unable to fill your prescription, they may have direct contacts with pharmacies or can manage a transition to an alternative medication safely.

Never stop abruptly: Stopping clorazepate suddenly can cause life-threatening withdrawal including seizures. Always contact your doctor if you're at risk of running out.

Looking Ahead

The clorazepate supply situation in 2026 is improving but not fully resolved. The addition of ANI Pharmaceuticals as a new generic manufacturer is a positive step toward better availability and pricing over the next 12-18 months. In the meantime, plan refills early, use every tool available to find your medication, and communicate proactively with your prescriber. For more background on why this situation exists, see our full article on why Tranxene is hard to find in 2026.